Literature DB >> 2907688

Separation and characterization of four different amino acid sequence variants of a sea anemone (Stichodactyla helianthus) protein cytolysin.

W R Kem1, B M Dunn.   

Abstract

A basic protein cytolysin previously isolated from the Caribbean sea anemone Stichodactyla helianthus was shown by CM cellulose chromatography to consist of four isotoxins possessing different N-terminal amino acid sequences. These are designated as toxins I-IV in order of increasing isoelectric point. The estimated molecular sizes (17,400-18,200) of toxins I-III were very similar; toxins I and II posses one additional amino acid at their amino terminus relative to toxin III. Under denaturing conditions, toxin IV behaved as a significantly larger (19,600) polypeptide; Edman sequencing established that it possesses a seven residue extension at the N-terminal end relative to toxin III. None of the variants contained half-cystines or reducing sugars. Toxin III contributed 83% of the total purified cytolytic (hemolytic) activity, toxin II 14%, and the relatively insoluble toxins I and IV together only contributed about 3% of the total cytolytic activity. Cytolysin III lysed Ehrlich ascitic tumour cells, but when administered intraperitoneally in nonlethal doses to mice already inoculated with this tumour, it failed to protect the mice against the tumour. Comparison of the partial amino acid sequence of equinatoxin, another sea anemone protein cytolysin, with that of Stichodactyla cytolysin III indicates they are highly homologous. Many other cytolytic proteins isolated from sea anemones share these properties with Stichodactyla cytolysins: (1) selective inhibition of hemolytic activity by preincubation with sphingomyelin, (2) a molecular size of 10,000-20,000, and (3) an isoelectric point of 9 or above.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2907688     DOI: 10.1016/0041-0101(88)90198-5

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  7 in total

1.  Effect of human serum albumin upon the permeabilizing activity of sticholysin II, a pore forming toxin from Stichodactyla heliantus.

Authors:  Gloria Celedón; Gustavo González; Felipe Gulppi; Fabiola Pazos; María E Lanio; Carlos Alvarez; Cristian Calderón; Rodrigo Montecinos; Eduardo Lissi
Journal:  Protein J       Date:  2013-12       Impact factor: 2.371

2.  Sphingolipids and Cholesterol.

Authors:  Xian-Cheng Jiang; Zhiqiang Li
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

3.  Inactivation of the pore-forming toxin Sticholysin I by peroxynitrite: protection by cys groups incorporated in the toxin.

Authors:  L León; E A Lissi; G Celedón; G Gonzalez; F Pazos; C Alvarez; M E Lanio
Journal:  Protein J       Date:  2014-10       Impact factor: 2.371

4.  Purification and characterization of gigantoxin-4, a new actinoporin from the sea anemone Stichodactyla gigantea.

Authors:  Bo Hu; Wei Guo; Liang-Hua Wang; Jian-Guang Wang; Xiao-Yu Liu; Bing-Hua Jiao
Journal:  Int J Biol Sci       Date:  2011-06-07       Impact factor: 6.580

5.  Development of highly selective Kv1.3-blocking peptides based on the sea anemone peptide ShK.

Authors:  Michael W Pennington; Shih Chieh Chang; Satendra Chauhan; Redwan Huq; Rajeev B Tajhya; Sandeep Chhabra; Raymond S Norton; Christine Beeton
Journal:  Mar Drugs       Date:  2015-01-16       Impact factor: 5.118

6.  Self-homodimerization of an actinoporin by disulfide bridging reveals implications for their structure and pore formation.

Authors:  Aisel Valle; Luis Benito Pérez-Socas; Liem Canet; Yadira de la Patria Hervis; German de Armas-Guitart; Diogo Martins-de-Sa; Jônatas Cunha Barbosa Lima; Adolfo Carlos Barros Souza; João Alexandre Ribeiro Gonçalves Barbosa; Sonia Maria de Freitas; Isabel Fabiola Pazos
Journal:  Sci Rep       Date:  2018-04-26       Impact factor: 4.379

Review 7.  Response of Cellular Innate Immunity to Cnidarian Pore-Forming Toxins.

Authors:  Wei Yuen Yap; Jung Shan Hwang
Journal:  Molecules       Date:  2018-10-04       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.